{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:17:46Z","timestamp":1782883066977,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/hjh.0b013e32834e1eda","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T18:37:35Z","timestamp":1322851055000},"page":"188-193","source":"Crossref","is-referenced-by-count":22,"title":["Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors"],"prefix":"10.1097","volume":"30","author":[{"given":"Marina","family":"De Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"de Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210208","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R2-26-20210208","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch Intern Med"},{"key":"R3-26-20210208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R4-26-20210208","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(96)07099-7","article-title":"Blood-pressure control in the hypertensive population.","volume":"349","author":"Mancia","year":"1997","journal-title":"Lancet"},{"key":"R5-26-20210208","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"key":"R6-26-20210208","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc06-2152","article-title":"Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.","volume":"30","author":"de Simone","year":"2007","journal-title":"Diabetes Care"},{"key":"R7-26-20210208","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994.","volume":"163","author":"Park","year":"2003","journal-title":"Arch Intern Med"},{"key":"R8-26-20210208","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.0000088846.10655.E0","article-title":"The metabolic syndrome: more than the sum of its parts C","volume":"108","author":"Reilly","year":"2003","journal-title":"irculation"},{"key":"R9-26-20210208","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2003.12.049","article-title":"Prognostic value of the metabolic syndrome in essential hypertension.","volume":"43","author":"Schillaci","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R10-26-20210208","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.104.516948","article-title":"Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study.","volume":"112","author":"Dekker","year":"2005","journal-title":"Circulation"},{"key":"R11-26-20210208","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.jhh.1002203","article-title":"Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.","volume":"21","author":"de Simone","year":"2007","journal-title":"J Hum Hypertens"},{"key":"R12-26-20210208","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/HJH.0b013e3282e9a9e4","article-title":"Association of suboptimal blood pressure control with body size and metabolic abnormalities.","volume":"25","author":"Arcucci","year":"2007","journal-title":"J Hypertens"},{"key":"R13-26-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2840-8-51","article-title":"Blood pressure control and components of the metabolic syndrome: the GOOD survey.","volume":"8","author":"Zidek","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"R14-26-20210208","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1157\/13102050","article-title":"Adequacy of the treatment of hypertensive patients with metabolic syndrome.","volume":"128","author":"Barrios","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"R15-26-20210208","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc08-1881","article-title":"Insufficient control of blood pressure and incident diabetes.","volume":"32","author":"Izzo","year":"2009","journal-title":"Diabetes Care"},{"key":"R16-26-20210208","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/01.hjh.0000173526.65555.55","article-title":"The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis.","volume":"23","author":"De Luca","year":"2005","journal-title":"J Hypertens"},{"key":"R17-26-20210208","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney FoundationNational Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R18-26-20210208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R19-26-20210208","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"European Society of HypertensionReappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"R20-26-20210208","first-page":"1183","article-title":"Diabetes C","volume":"20","year":"1997","journal-title":"are"},{"key":"R21-26-20210208","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R23-26-20210208","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.36.4.594","article-title":"Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community.","volume":"36","author":"Lloyd-Jones","year":"2000","journal-title":"Hypertension"},{"key":"R24-26-20210208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/VHRM.S2778","article-title":"Blood pressure normalization by fixed perindoprilindapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.","volume":"4","author":"Mourad","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"R25-26-20210208","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"SHEP cooperative research groupInfluence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program.","volume":"158","author":"Savage","year":"1998","journal-title":"Arch Intern Med"},{"key":"R26-26-20210208","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(82)91506-9","article-title":"Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up.","volume":"2","author":"Murphy","year":"1982","journal-title":"Lancet"},{"key":"R27-26-20210208","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","article-title":"Adverse prognostic significance of new diabetes in treated hypertensive subjects.","volume":"43","author":"Verdecchia","year":"2004","journal-title":"Hypertension"},{"key":"R28-26-20210208","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1161\/CIRCULATIONAHA.107.709931","article-title":"Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension.","volume":"117","author":"Cutler","year":"2008","journal-title":"Circulation"},{"key":"R29-26-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/dc07-1452","article-title":"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialMetabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"31","author":"Black","year":"2008","journal-title":"Diabetes Care"},{"key":"R30-26-20210208","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome.","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol Behav"},{"key":"R31-26-20210208","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.0197-3118.2006.05422.x","article-title":"The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.","volume":"1","author":"Sharma","year":"2006","journal-title":"J Cardiometab Syndr"},{"key":"R32-26-20210208","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1152\/ajpregu.00507.2004","article-title":"AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity.","volume":"289","author":"Boustany","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R33-26-20210208","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.HYP.0000259737.43916.42","article-title":"Do statins reduce blood pressure A meta-analysis of randomized, controlled trials.","volume":"49","author":"Strazzullo","year":"2007","journal-title":"Hypertension"},{"key":"R34-26-20210208","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.amjhyper.2007.03.018","article-title":"Use of statins and blood pressure.","volume":"20","author":"King","year":"2007","journal-title":"Am J Hypertens"},{"key":"R35-26-20210208","first-page":"MS1","article-title":"Time for new indications for statins Med Sci M","volume":"15","author":"Banach","year":"2009","journal-title":"onit"},{"key":"R36-26-20210208","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins.","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arteroscler Thromb Vasc Biol"},{"key":"R37-26-20210208","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"R38-26-20210208","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(02)01717-5","article-title":"Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension.","volume":"39","author":"Ferrier","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e32834e1eda","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:38:43Z","timestamp":1621885123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201201000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32834e1eda","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}